-
The National Drug Abuse Treatment Clinical Trials Network: Forging a partnership between research knowledge and community practice.
Tai B, Sparenborg S, Liu DS, Straus MM. The National Drug Abuse Treatment Clinical Trials Network: Forging a partnership between research knowledge and community practice. Substance Abuse and Rehabilitation 2011;2:21-28.
-
Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network.
Wu L, Ling W, Burchett B, Blazer DG, Yang C, Pan J, Reeve BB, Woody GE. Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network. Drug and Alcohol Dependence 2011;118(2-3):186-193.
-
Retention in the National Institute on Drug Abuse Clinical Trials Network Women and Trauma study: Implications for posttrial implementation.
Pinto RM, Campbell ANC, Hien DA, Yu G, Gorroochurn P. Retention in the National Institute on Drug Abuse Clinical Trials Network Women and Trauma study: Implications for posttrial implementation. American Journal of Orthopsychiatry 2011;81(2):211-217.
-
Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit/hyperactivity disorder and substance use disorders.
Gray KM, Riggs PD, Min SJ, Mikulich-Gilbertson SK, Bandyopadhyay D, Winhusen TJ. Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit/hyperactivity disorder and substance use disorders. Drug and Alcohol Dependence 2011;117(2-3):242-247.
-
Program, counselor, and patient variability in the alliance: A multilevel study of the alliance in relation to substance use outcomes.
Crits-Christoph P, Hamilton JL, Ring-Kurtz S, Gallop R, McClure B, Kulaga A, Rotrosen J. Program, counselor, and patient variability in the alliance: A multilevel study of the alliance in relation to substance use outcomes. Journal of Substance Abuse Treatment 2011;40(4):405-413.
-
Substance abuse counselors’ implementation of tobacco cessation guidelines.
Rothrauff TC, Eby LT. Substance abuse counselors' implementation of tobacco cessation guidelines. Journal of Psychoactive Drugs 2011;43(1):6-13.
-
Ten take home lessons from the first 10 Years of the CTN and 10 recommendations for the future.
Carroll KM, Ball SA, Jackson TR, Martino S, Petry NM, Stitzer ML, Wells EA, Weiss RD. Ten take home lessons from the first 10 Years of the CTN and 10 recommendations for the future. American Journal of Drug and Alcohol Abuse 2011;37(5):275-282.
-
Addicted to discovery: Does the quest for new knowledge hinder practice improvement?
Perl HI. Addicted to discovery: Does the quest for new knowledge hinder practice improvement? Addictive Behaviors 2011;36(6):590-596.
-
HIV rapid testing in substance abuse treatment: Implementation following a clinical trial.
Haynes LF, Korte JE, Holmes BW, Gooden LK, Matheson T, Feaster DJ, Leff JA, Wilson L, Metsch LR, Schackman BR. HIV rapid testing in substance abuse treatment: Implementation following a clinical trial. Evaluation and Program Planning 2011;34(4):399-406.
-
Clinical correlates of health-related quality of life among opioid-dependent patients.
Heslin KC, Stein JA, Heinzerling KG, Pan D, Magladry C, Hays RD. Clinical correlates of health-related quality of life among opioid-dependent patients. Quality of Life Research 2011;20(8):1205-1213.